
BioUtah Organizes Stryker, bioMérieux Tours for State Legislators
June 20, 2024
State legislators yesterday got a first hand look at Utah’s life sciences industry, touring Stryker Neurovascular and bioMérieux. Stryker and bioMérieux, two leading life sciences employers in the state, discussed their innovative healthcare technologies with the eight lawmakers.
At Stryker, the tour featured the manufacturing of the company’s stroke intervention technologies and physician training facilitiy. Stryker’s stroke technology has become a standard of care and saved countless lives.
bioMeriéux leadership took State Senators and Representatives through the company’s reagent facility, where their primary products are developed for an array of infectious disease diagnostics.
“These tours in the field, organized by BioUtah in conjunction with AdvaMed and the Utah Life Sciences Innovation Caucus, give legislators a bird’s eye view of the innovation taking place in Utah and help them better understand the industry’s role in changing patients’ lives,” said Kelvyn Cullimore, president and CEO of BioUtah. “We thank the legislators for taking the time to make these personal visits and we look forward to working with them to continue to advance healthcare.”
AdvaMed’s Darbi Gottlieb also attended the tours, underscoring the national association’s partnership with BioUtah and commitment to med tech.
“Together, with AdvaMed, we work to support our industry,” added Cullimore.


Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp














